Boeing’s highly anticipated 777X widebody jet is facing another setback, with deliveries now pushed back to early 2027 instead of next year, according to a Bloomberg report citing industry sources. This marks yet another delay for the flagship aircraft program, which was originally expected to enter service in 2020.
Launch customer Deutsche Lufthansa AG is already adjusting its fleet strategy and does not expect the 777X to be operational before 2027. Boeing, meanwhile, declined to comment on the latest delay.
The extended timeline is likely to come with financial consequences. Several Wall Street analysts forecast that Boeing could announce a charge between $1 billion and $4 billion in its upcoming third-quarter earnings report to account for the delay. The company has already absorbed more than $10 billion in charges since the program’s launch in 2013.
Boeing CEO Kelly Ortberg recently admitted that certification efforts remain behind schedule, describing the process as a “mountain of work.” While Ortberg emphasized that no new technical flaws have emerged, the slow pace of regulatory approval continues to hinder progress. The aircraft was last scheduled for delivery in 2026, already six years late.
Investment analysts are now lowering their projections for Boeing’s free cash flow in 2026, anticipating financial strain from the extended delay. RBC Capital Markets aerospace analyst Ken Herbert told investors he expects deliveries to start no earlier than the second half of 2027.
The 777X, designed as Boeing’s most advanced widebody jet with improved fuel efficiency and larger capacity, has been positioned as a critical program for the company’s long-term competitiveness against Airbus. However, repeated delays and mounting costs highlight the challenges Boeing faces in regaining market confidence and meeting airline demand.
With certification hurdles still looming, the 777X’s future timeline remains uncertain, casting another shadow over Boeing’s financial recovery and strategic outlook.


Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
First Western Ship Transits Strait of Hormuz Since Iran War Began
Apple Turns 50: From Garage Startup to AI Crossroads
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 



